VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 132 filers reported holding VOYAGER THERAPEUTICS INC in Q3 2019. The put-call ratio across all filers is - and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q2 2024 | $301,759 | -15.5% | 38,149 | -0.5% | 0.00% | -33.3% |
Q1 2024 | $357,066 | +19.4% | 38,353 | +8.2% | 0.00% | +50.0% |
Q4 2023 | $299,080 | +1.8% | 35,436 | -6.5% | 0.00% | 0.0% |
Q3 2023 | $293,725 | -7.9% | 37,900 | -44.1% | 0.00% | -33.3% |
Q1 2021 | $319,000 | -33.4% | 67,782 | +1.1% | 0.00% | -40.0% |
Q4 2020 | $479,000 | -5.9% | 67,021 | +40.4% | 0.01% | -28.6% |
Q3 2020 | $509,000 | -20.5% | 47,730 | -5.9% | 0.01% | -22.2% |
Q2 2020 | $640,000 | +3.7% | 50,696 | -24.8% | 0.01% | -10.0% |
Q1 2020 | $617,000 | -41.2% | 67,397 | -10.4% | 0.01% | +25.0% |
Q4 2019 | $1,050,000 | -17.2% | 75,260 | +2.1% | 0.01% | -20.0% |
Q3 2019 | $1,268,000 | -39.6% | 73,684 | -4.4% | 0.01% | -37.5% |
Q2 2019 | $2,098,000 | +39.4% | 77,092 | -2.0% | 0.02% | +45.5% |
Q1 2019 | $1,505,000 | +112.9% | 78,637 | +4.5% | 0.01% | +120.0% |
Q4 2018 | $707,000 | -34.9% | 75,243 | +31.1% | 0.01% | -28.6% |
Q3 2018 | $1,086,000 | +18.6% | 57,399 | +22.4% | 0.01% | +16.7% |
Q2 2018 | $916,000 | – | 46,900 | – | 0.01% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
TRV GP III, LLC | 3,185,291 | $24,558,594 | 29.60% |
EcoR1 Capital, LLC | 3,851,507 | $29,695,119 | 0.96% |
ARMISTICE CAPITAL, LLC | 3,524,000 | $27,170,040 | 0.39% |
EAM Investors, LLC | 123,818 | $954,637 | 0.19% |
HARBOURVEST PARTNERS LLC | 61,776 | $476,293 | 0.16% |
Diametric Capital, LP | 12,527 | $96,583 | 0.05% |
Campbell & CO Investment Adviser LLC | 30,563 | $235,641 | 0.04% |
CAXTON ASSOCIATES LP | 36,564 | $281,908 | 0.04% |
FIDUCIARY TRUST CO | 252,303 | $1,945,256 | 0.04% |
GLOBEFLEX CAPITAL L P | 36,109 | $278,400 | 0.03% |